Bill

Bill > SB263


NM SB263

NM SB263
Opioid Prescription Monitoring


summary

Introduced
01/25/2016
In Committee
02/03/2016
Crossed Over
02/04/2016
Passed
02/08/2016
Dead
Signed/Enacted/Adopted
02/08/2016

Introduced Session

2016 Regular Session

Bill Summary

Opioid Prescription Monitoring

AI Summary

This bill establishes new requirements for healthcare practitioners in New Mexico regarding the prescription of opioids, which are a class of pain-relieving drugs derived from opium or synthesized to act on similar receptors. Specifically, before a practitioner, excluding pharmacists, veterinarians, or euthanasia technicians, prescribes or dispenses an opioid for the first time to a patient, they must obtain and review a report from the state's Prescription Monitoring Program (PMP) for the previous twelve months, and also any similar reports from adjacent states if available, though this requirement does not apply to prescriptions for four days or less. For established patients who are continuously prescribed or dispensed opioids, practitioners must review these PMP reports at least every three months, documenting these reviews in the patient's medical record. The bill clarifies that practitioners can obtain these reports more frequently if they deem it necessary based on their professional judgment and that these requirements do not apply to opioid prescriptions for patients in nursing facilities or hospice care, with professional licensing boards responsible for creating rules to implement these provisions, potentially requiring more frequent reporting.

Committee Categories

Government Affairs, Justice

Sponsors (1)

Last Action

[LD 21] Signed by the Governor - Chapter 46 (on 02/08/2016)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...